Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Center for Precision Diabetic Medicine,PreciDIAB | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Populations in precarious situations or with low socio-economic status have an increased risk of diabetes and accelerated aging. According to the population studied, the elements that can explain these health inequalities are not unequivocal and remain poorly known.
The north of France, particularly affected by socio-economic disparities, has a prevalence of diabetes among the highest in metropolitan France. This is why investigators want to study the clinical, biological, social and behavioural risk factors of the entry into diabetes and accelerated aging among a large population in the North of France.
This study aims to characterize the population (among which a majority (55%) suffers from precarious conditions) who come to carry out their health examination at the Pasteur Institute in Lille in order to study the risk factors to better explain these health inequalities.
This research consists of a main descriptive observational, cross-sectional study carried out on 2233 volunteers (main group) over 18 months, and a complementary analytical case-control study that will be offered to 216 participants (sub-group).
Primary Objective : Assessment of Prevalence of Prediabetes and Diabetes by Socio-Economic Status
Primary efficacy endpoint : Fasting glucose value based on EPICES score :
Glycemia:
EPICES score: quintiles of score distribution (Q1 to Q5)
Secondary Objectives specific to the main group:
Secondary Objectives specific to the sub-group:
Secondary endpoints specific to the main group: :
Prevalence ratio of diabetes and prediabetes calculated for:
Assessment of the level of ageing
Prevalence ratio of (pre)diabetes and accelerated aging according to socio-economic status
Secondary endpoints specific to the subgroup:
Risk (OR) of (pre)diabetes and accelerated aging according to social, economic, cultural and marital status
Evaluation of (pre)diabetes: fasting blood sugar
Accelerated Aging Assessment: DNAmPhenoAge
Socio-economic and cultural criteria
Risk (OR) of (pre)diabetes and accelerated aging for assessed exposures:
Evaluation of (pre)diabetes: fasting blood sugar
Accelerated Aging Assessment: DNAmPhenoAge
Exposure Assessment
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Main group | Cross-sectional study |
| |
| Sub group | Case control study |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Biological analysis, Physical examination and Questionnaires | Other | Biological analysis, Physical examination and questionnaires will be performed for all patients of the main group. |
| Measure | Description | Time Frame |
|---|---|---|
| Fasting glucose value according to the level of precariousness | Glycemia in g/L Level of precariousness given by EPICES score | Day 0 |
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence ratio of (pre)diabetes calculated for clinical, biological and behavioral/environmental explanatory variables | In % | Day 0 |
| Assessment of the level of accelerated ageing (DNAmPhenoAge) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Populations in precarious situations or with a low socioeconomic level have an increased risk of entering diabetes and aging accelerated. Depending on the populations studied, the elements that could explain these health inequalities are not unequivocal and are still badly known.
The Hauts-de-France region, particularly affected by disparities socio-economic, has one of the most prevalent diabetes high in the metropolis. This is why it's important to study the factors clinical, biological, social and behavioral risks of entry in diabetes and accelerated aging in a large population of North of France.
This study aims to characterize the population of the Centre's consultants of Health Examinations at the Institut Pasteur de Lille, of which a majority (55%) suffers from precarious conditions, in order to study the risk factors to better explain these health inequalities.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Philippe Dr FROGUEL, PhD | PRECIDIAB | Study Chair |
| Matthias Mr VANDESQUILLE, PhD | PRECIDIAB | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institut Pasteur de Lille | Lille | Hauts-de-France | 59019 | France |
Not provided
| Label | URL |
|---|---|
| National Center for Precision Medicine on Diabetes - PreciDIAB | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
DNA methylation
| Physical examination and Questionnaires | Other | In addition to exams for the main group, there will be 2 additional examinations (bone densitometry and arterial stiffness) for the patients of the subgroup and others questionnaires. |
|
In units of years
| Day 0 |
| Prevalence ratio of (pre) diabetes and accelerated aging according to the socio-economic status | In % | Day 0 |
| Risk (odds Ratio) of (pre) diabetes and accelerated aging according to social, economic, cultural and professional status | Without units | Until Day 90 |
| Risk (odds Ratio) of (pre) diabetes and accelerated aging for assessed exposures | Without units | Until Day 90 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D011236 | Prediabetic State |
| D018149 | Glucose Intolerance |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D006943 | Hyperglycemia |
Not provided
Not provided
| ID | Term |
|---|---|
| D012149 | Restraint, Physical |
| D011795 | Surveys and Questionnaires |
| ID | Term |
|---|---|
| D032763 | Behavior Control |
| D013812 | Therapeutics |
| D007103 | Immobilization |
| D008919 | Investigative Techniques |
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D017531 | Health Care Evaluation Mechanisms |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |
Not provided
Not provided